Libro Achieves Record-Breaking Sales and 65% Revenue Growth in 2023
MONTREAL–(BUSINESS WIRE)–Libro, a leading innovator in reservations and guest experience solutions for the restaurant industry, announced today that... Read more.
Owens Corning to Announce Fourth-Quarter and Full-Year 2023 Financial Results on February 14
TOLEDO, Ohio–(BUSINESS WIRE)–Owens Corning (NYSE: OC) is scheduled to announce its fourth-quarter and full-year 2023 financial results on Wednesday,... Read more.
Monro, Inc. Announces Third Quarter Fiscal 2024 Financial Results
Third Quarter Sales Decreased to $317.7 Million Third Quarter Comparable Store Sales Decreased 6.1% Third Quarter Diluted EPS of $.38; Adjusted Diluted EPS1 of $.39... Read more.
Harvest Declares Big Pharma Split Corp. January 2024 Distributions
OAKVILLE, Ontario–(BUSINESS WIRE)–Harvest Portfolios Group Inc. (“Harvest”) declares the monthly cash distribution payable for Big Pharma Split Corp.... Read more.
Credit Benchmark says US oil & gas industry has most benign default risk outlook vs. other US sectors, as discussed in 2024 Default Risk Outlook report on 13 US industries
NEW YORK–(BUSINESS WIRE)–#banking–Credit Benchmark, the provider of global credit consensus ratings and analytics, today said that the already... Read more.
Italy Alternative Lending Market Databook 2023 – Compound Annual Growth of 8.8% During 2023-2027, with Market to Reach US$8.41 Billion by 2027 – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Italy Alternative Lending Market Business and Investment Opportunities Databook – 75+ KPIs on Alternative Lending... Read more.
Nexo Sues Bulgaria for Over $3 Billion
ZUG, Switzerland–(BUSINESS WIRE)–$NEXO—Nexo AG and its subsidiaries have filed an over $3 billion ICSID arbitration claim against the Republic... Read more.
MAIA Biotechnology Announces Publication of International PCT Patent Application Covering Anticancer Telomere-Targeting Compounds
New patent would extend coverage and expand potential value of MAIA’s telomere-targeting platform globally CHICAGO–(BUSINESS WIRE)–MAIA Biotechnology,... Read more.
MiNA Therapeutics Presents New Data for its HbF Program at the Keystone Symposia’s Delivery of Nucleic Acid Therapeutics Conference
Pre-clinical studies confirm in vivo delivery of small activating RNA therapeutics to erythroid progenitor cells at clinically meaningful levels Compelling pre-clinical... Read more.
Synnovation Therapeutics Launches with $102 Million to Advance Clinical-Stage Pipeline of Precision Therapies Targeting Highly Validated Disease Pathways
– Series A Financing led by Third Rock Ventures and includes Nextech, Lilly Asia Ventures, Sirona Capital and Cormorant Asset Management – WILMINGTON,... Read more.